CIBC World Market’s CONMED CNMD Stock Holding History

CIBC World Market’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-16,965	Closed	-$1.9M	–	1010
2019 Q4	$1.9M	Buy	+16,965	New	+$1.81M	0.01%	509

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

CIBC World Market's CNMD Position: Q1 2020 in Review

CIBC World Market sold out of CONMED (CNMD) in Q1 2020, closing a stake of 16,965 shares — an estimated $1.9M sold.

CIBC World Market first reported a position in CNMD in Q4 2019 and held it in 1 quarter. The position peaked at $1.9M in Q4 2019. 228 funds tracked by Wall St. Rank hold CNMD as of Q1 2020.

CIBC World Market reported no remaining CONMED position as of Q1 2020 after selling out during the quarter.
CIBC World Market sold 16,965 CONMED shares in Q1 2020, an estimated $1.9M.
CIBC World Market first reported a position in CONMED in Q4 2019 and held it in 1 quarter.
CIBC World Market's CONMED position peaked at $1.9M in Q4 2019.
228 funds tracked by Wall St. Rank held CONMED as of Q1 2020.

Based on CIBC World Market's 13F filing for Q1 2020, filed 15 May 2020.